Reach a New Level of Efficiency in Gene Therapy Manufacturing

Gene therapies are among the most complex therapeutics ever devised. But the process to manufacture them doesn’t have to be. The challenge is knowing what tools, technologies, and services are available and which will be the best fit for your workflow and organization.

In this series of articles, we share considerations for selecting an integrated solutions and services provider and highlight the latest advances that address some of the most problematic steps in the gene therapy production process.

Find an integrated solutions and services provider to support and optimize your entire gene therapy production workflow. Click here to find the perfect fit.

With a large number of suppliers of gene therapy manufacturing technologies to choose from, what are some strategies to find the best partner? Click here to find out.

Check out new purification strategies for effective separation of full and empty AAV capsids and achieve a new level of efficiency in the downstream workflow. Click here to read the article.

Benefit from a new insect cell line platform to improve the safety profile of baculovirus processes and get high production of recombinant proteins, virus-like particles, and AAV. Click here to read the article.

Learn about a new medium designed for maximize AAV production across multiple HEK293 lineages. Click here to read the article.